Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.7 |